Market Access
From authorization to availability — so your approved product actually sells
Registration gets you a licence. It doesn't get you sales. We bridge that gap.
What we do
How this service works
Too many companies treat approval as the finish line, then discover the product still isn’t reaching patients — because it isn’t priced, listed, reimbursed, or aligned to the procurement cycles that govern how medicines are actually bought in Africa. Market access is where authorization turns into revenue.
-
01
Market entry & feasibility assessment
demand, competition, pricing landscape, and route-to-market by country
-
02
Pricing & reimbursement
strategy aligned to national systems, insurance schemes, and affordability realities
-
03
Tender & procurement navigation
aligning registration and supply with public tenders and the cycles that decide when your product can be bought
-
04
Donor & global-health mechanisms
engagement with Gavi, the Global Fund, and pooled procurement channels
-
05
Stakeholder & government affairs
Ministries of Health, procurement agencies, and national programs
-
06
Local partner & distributor identification
sourcing and due-diligence on credible in-country partners
-
07
Import, GDP & supply-chain compliance
ensuring the approved product can actually move and stay available
Ready to move on Market Access?
Tell us your product and target markets — we'll map the fastest compliant path.